Hip Surveillance in Patients with Cerebral Palsy: Our Center Experience

Authors

  • Diana Ascenso Serviço de Medicina Física e de Reabilitação, Hospital Garcia de Orta
  • Filipe Matos Serviço de Medicina Física e de Reabilitação, Hospital Garcia de Orta
  • Margarida Freitas Serviço de Medicina Física e de Reabilitação, Hospital Garcia de Orta
  • Ana Sofia Neves Serviço de Ortopedia e Traumatologia, Hospital Garcia de Orta
  • Carolina Escalda Serviço de Ortopedia e Traumatologia, Hospital Garcia de Orta
  • Susana Almeida Centro de Desenvolvimento da Criança, Hospital Garcia de Orta
  • Cristina Duarte Centro de Desenvolvimento da Criança, Hospital Garcia de Orta

DOI:

https://doi.org/10.25759/spmfr.333

Keywords:

Cerebral Palsy/complications, Child, Hip, Hip Dislocation/prevention & control, Risk Assessment

Abstract

Introduction: Our objective was to characterize patients under 18 years old with cerebral palsy (CP), followed in our center, regarding their clinical and functional characterization and the presence of hip deformities, as well as surgical orientations.

Material and Methods: Retrospective cross-sectional study based on the files of patients with CP, clinical registers, and serial radiological evaluation of hips according to the Australian Hip Surveillance Program (HSP). Analysis of the group with functional classifications IV and V and characterization of hip deformities: radiological evaluation of the femoral migration index (MI). Subanalysis of patients submitted to orthopedic surgery and patients not submitted to any surgery. The presentation of the results was divided into age groups (1-5 years; 6 – 11 years; 12-18years), according to the coverage of the HSP implemented, in 2012, at our center.

Results: Of the total of 285 children with PC, the group with functional levels IV and V had 88 patients. From these group, more than half had subluxation of the hip. Were excluded 30 children. The total non-operated children was 35, the mean MI was 31.6%. The age group of 1-5 years had 3 patients, with a MI of 33.5% and the mean of the last hip radiograph was 7.1 months. The group of 6-11 years had 13 patients, with MI of 32.2%, and the mean of the last radiograph was 11.6 months. The 12-18 years group had 19 patients with a MI of 30.9% and the mean of the last radiograph was 24.5 months. The total operated patients was 23. From these group, 4 were operated before the implementation of the hip surveillance program. After 2012, 19 patients were operated. From these group, 6 were operated with preventive tenotomies and mean of 5 years.

Conclusion: About half of the patients with IV and V functional levels had subluxation of the hip. About 38% of these patients have already submitted to surgery. From these group, 1/3 were tenotomies with early ages. Patients who are not surgically treated are under hip surveillance. In this population there is a high prevalence of this hip deformity. However, articulation with orthopedics has allowed early surgical interventions.

Downloads

Download data is not yet available.

References

Miller SD, Juricic M, Hesketh K, Mclean L, Magnuson S, Gasior S, et al. Prevention of hip displacement in children with cerebral palsy: a systematic review. Dev Med Child Neurol. Dev Med Child Neurol. 2017;59(11):1130-1138.

Shore B, Shrader M, Narayanan U, Miller F, Graham H, Mulpuri K. Hip Surveillance for Children With Cerebral Palsy: A Survey of the POSNA Membership. J Pediatr Orthop. 2017;37(7):e409-e414.

Dobson F, Boyd R, Parrott J, Nattrass G, Graham H. Hip surveillance in children with cerebral palsy. J Bone Joint Surg Br. 2002;84(5):720-6.

Kim SM, Sim EG, Lim SG, Park ES. Reliability of hip migration index in children with cerebral palsy: the classic and modified methods. Ann Rehabil Med. 2012;36(1):33-8

Soo B, Howard JJ, Boyd RN, Reid SM, Lanigan A, Wolfe R, et al. Hip displacement in cerebral palsy. J Bone Joint Surg Am. 2006;88(1):121-9.

Deshpande A, Gormley M, Deshpande S. The risk of hip subluxation is less in children with dystonic cerebral palsy than children with spasticity. Dev Med Child Neurol. 2016;58;S5:63.

Graham H, Rosenbaum P, Paneth N, Dan B, Lin J, Damiano D, et al. Cerebral palsy. Nat Rev Dis Primers. 2016;7(2):15082.

Pruszczynski B, Sees J, Miller F. Risk Factors for Hip Displacement in Children With Cerebral Palsy: Systematic Review. J Pediatr Orthop. 2016; 36(8):829-833.

Illescas JA, Barriga A, Beguiristain JL. Prevención de la luxación de cadera en niños con parálisis cerebral mediante tenotomía de adductores y psoas. Rev Ortop Traumatol. 2003;47:270-274.

Reimeirs J. The Stability of the Hip in Children: A Radiological Study of the Results of Muscle Surgery in Cerebral Palsy. Acta Orthopaedica Scandinavica. 1980;sup184,1-100.

Parrott JK, Boyd RN, Smithson FL. Reliability of radiological measures of hip displacement in children with spastic cerebral palsy. Dev Med Child Neurol. 2000; S83,42:5-6.

Pountney TE, Mandy A, Green E, Gard PR. Hip subluxation and dislocation in cerebral palsy - a prospective study on the effectiveness of postural management programmes. Physiother Res Int. 2009;14(2):116-127.

Macias-Merlo L, Bagur-Calafat C, Girabent-Farres M, Stuberg WA. Effects of the standing program with hip abduction on hip acetabular development in children with spastic diplegia cerebral palsy. Disability Rehabilitation. 2016;38(11):1075-81.

Love SC, Novak I, Kentish M, Desloovere K, Heinen F, Molenaers G, O'Flaherty S, Graham HK. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. European Journal of Neurology 2010;17 (Suppl. 2): 9–37.

Wang KK, Munger ME, Chen BP, Novacheck TF. Selective dorsal rhizotomy in ambulant children with cerebral palsy. J Child Orthop. 2018;1;12(5):413-427.

Hasnat MJ, Rice JE. Intrathecal baclofen for treating spasticity in children with cerebral palsy. Cochrane Database Syst Rev. 2015;13(11):CD004552.

Shore B, Graham HK. Management of Moderate to Severe Hip Displacement in Nonambulatory Children with Cerebral Palsy. JBJS Reviews. 2017; 5(12):e4.

Graham HK, Boyd R, Carlin JB, et al. Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial. J Bone Joint Surg Am. 2008;90(1):23-33.

Hägglund G, Alriksson-Schmidt A, Lauge-Pedersen H, Rodby-Bousquet E, Wagner P, Westbom L. Prevention of dislocation of the hip in children with cerebral palsy: 20-year results of a population-based prevention programme. Bone Joint J. 2014;96-B(11):1546-52.

JR., Davids. Management of Neuromuscular Hip Dysplasia in Children With Cerebral Palsy: Lessons and Challenges. J Pediatr Orthop. 2018;38 Suppl 1:S21-S27.

Hägglund G, Andersson S, Düppe H, Lauge-Pedersen H, Nordmark E, Westbom L. Prevention of dislocation of the hip in children with cerebral palsy. The first ten years of a population-based prevention programme. J Bone Joint Surg Br. 2005;87(1):95-101.

Wynter M, Gibson N, Willoughby KL, Love S, Kentish M, Thomason P, et al. National Hip Surveillance Working Group. Australian hip surveillance guidelines for children with cerebral palsy: 5-year review. Dev Med Child Neurol. 2015;57(9):808-20.

Shore B, Spence D, Graham HK. The role for hip surveillance in children with cerebral palsy. Curr Rev Musculoskelet Med (2012) 5:126–134.

Wynter M, Gibson N, Kentish M, Love S, Thomason P, Kerr Graham H. The Consensus Statement on Hip Surveillance for Children with Cerebral Palsy: Australian Standards of Care. J Pediatr Rehabil Med. 2011;4(3):183-95.

Published

2020-06-17

How to Cite

1.
Ascenso D, Matos F, Freitas M, Neves AS, Escalda C, Almeida S, et al. Hip Surveillance in Patients with Cerebral Palsy: Our Center Experience. SPMFR [Internet]. 2020 Jun. 17 [cited 2024 Nov. 24];32(1):15-23. Available from: https://spmfrjournal.org/index.php/spmfr/article/view/333

Issue

Section

Original Article

Similar Articles

<< < 8 9 10 11 12 13 

You may also start an advanced similarity search for this article.